Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 Infection and Inflammation in Human Adipose Tissue

NCT05833217 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05833217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 Infection and Inflammation in Human Adipose Tissue
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Recruiting
Start date
June 6, 2023
Completion date
December 31, 2025
Enrollment
55 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, insulin sensitivity, long covid